Multiple myeloma: open trials in Singapore

• NCT06615479

  A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

  Trial Treatment · Phase 3 · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

  Singapore · National University Hospital, Singapore

  Registry updated 2026-10-29

• NCT04973605

  A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

  Trial Treatment · Phase 1/2 · BeOne Medicines

  National University Hospital Singapore, Singapore

  Registry updated 2026-10-26

• NCT07735637

  A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).

  Trial Treatment · Phase 3 · AstraZeneca

  Singapore

  Registry updated 2026-10-21

• NCT05730036

  A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

  Trial Treatment · Phase 3 · Regeneron Pharmaceuticals

  Singapore General Hospital, Singapore · National University Hospital, Singapore

  Registry updated 2026-10-07

• NCT04988555

  A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

  Trial Treatment · Phase 1/2 · Sumitomo Pharma America, Inc.

  National University Cancer Institute, Singapore

  Registry updated 2026-03-24

• NCT06645678

  Mezigdomide and Elranatamab for Relapsed and/or Refractory Multiple Myeloma

  Trial Treatment · Phase 1/2 · YOUNGIL KOH

  National University Hospital (NUH), Singapore · Singhealth Duke NUS blood cancer center, Singapore

  Registry updated 2025-12-03

All Multiple myeloma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error